UHS uhsinc.com: Price-to-Projected Revenue Ratio

Corporate company logo of uhsinc.com (UHS)

The forward P/S ratio illustrates the valuation dynamics of Universal Health Services, whose resilience is based on a combination of psychiatry and general medicine. The current metric level of 0.70 confirms the maturity of the company's high-demand services. Business growth relies on economies of scale and the optimization of network capacity, allowing for the expansion of its presence without excessive capital expenditures.

UHS Universal Health Services, Inc.: Market Cap to Expected Sales Ratio in the range 07/04/2022 - 11/13/2026

uhsinc.com (UHS) - metric breakdowns and financial figures

Summary company analysis:Universal Health Services Corp UHS
Original product of Universal Health Services Inc

Universal Health Services, managing a network of clinics amid labor shortages and regulatory pressure, demonstrates a specific dependence of capitalization on operating income. The forward P/S ratio correlates the company's current market value with expected revenue, determining the premium the market is willing to pay for future sales. The trend in the forward P/S multiple reveals a risk of asset overvaluation, where a rapid increase in the coefficient complicates exiting a position during a crisis.

Key competitors

Forward P/S Multiple HCA (HCA Healthcare)|Tenet Healthcare Corp (THC) - Market Cap to Future Revenue Ratio|FMS - Price-to-Projected Revenue Ratio|Forward Price to Sales SOLV (Solventum Health)|Encompass Health (EHC) - Price-to-Projected Revenue Ratio|DVA - Market Cap to Expected Sales Ratio|RDNT (RadNet) - Forward P/S Multiple|Forward P/S Multiple Option Care|Price-to-Projected Revenue Ratio Surgery Partners Corp (SGRY)|Price-to-Projected Revenue Ratio PINC (Premier Health)|National Vision Holdings - Forward Price-to-Revenue Multiple|Forward Price to Sales PGNY|Ardent Health Partners - Forward P/S Multiple|Forward Price to Sales SEM (Select Medical Corporation)|ASTH: Forward P/S Multiple|Market Cap to Future Revenue Ratio MEDNAX (MD)|USPH (US Physical Therapy) - Forward P/S Multiple|Forward P/S Multiple pennantgroup.com|Price-to-Projected Revenue Ratio Organogenesis (ORGO)|Price-to-Projected Revenue Ratio NUTX (Nutex Health Inc)|Auna Health - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio SBC (SBC Medical Group Holdings)|Evolus, Inc. - Forward P/S Multiple|Forward Price to Sales CYH (chs.net)|SKIN (beautyhealth.com) - Forward Price-to-Revenue Multiple|MediWound - Forward Price to Sales|Price-to-Projected Revenue Ratio Biote Corp|The Joint (JYNT) - Market Cap to Expected Sales Ratio|Forward P/S Multiple DCGO|PIII - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Gain Therapeutics GANX|Forward Price to Sales EUDA|BMGL: Forward Price-to-Revenue Multiple|CLGN: Price-to-Projected Revenue Ratio|CUPR: Forward P/S Multiple|CCM - Market Cap to Expected Sales Ratio|AMS (American Shared Hospital Services) - Forward P/S Multiple|Forward Price-to-Revenue Multiple MEDIROM Healthcare Group Inc. (MRM)|Forward P/S Multiple ALBT|DHAI - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Longevity Health Holdings XAGE|Market Cap to Expected Sales Ratio newgenivf.com (NIVF)|ATIP: Forward Price-to-Revenue Multiple|CMAX - Forward P/S Multiple|KDLY: Forward P/S Multiple|ModivCare Corp - Forward Price to Sales|Price-to-Projected Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc (SSY) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple BACK (IMAC Holdings)